MedTrace Logo

Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis

NCT00869479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-12-15

No results posted yet for this study

Summary

The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.

Conditions

  • Nephrogenic Systemic Fibrosis

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Jonathan Kay, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00869479 on ClinicalTrials.gov